rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,15:29
1490.00
4.85 (0.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
68,963 1,485.15 1,506.75 - 1,470.05 1,581.70 - 1,028.00 120,332.41
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,15:55
1490.00
4.50 (0.30%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
1,328,847 1485.50 1,507.05 - 1,470.65 1,582.00 - 1,027.00 1,984,566,552.15

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36
Mahindra...
Mahindra Logistics Profit Drops 55% in Q1 FY25
Mahindra Logistics Ltd (MLL) reported a 55% decline in standalone profit to Rs 10.15 crore in the April-June quarter due to higher startup costs and expenses.
Jul 22, 2024 22:30
Mangaluru Airport...
Mangaluru Airport Passenger Traffic Rises 21% | Adani Airports
Mangaluru International Airport sees a 21% surge in passenger traffic in Q1 FY24-25, with Dubai leading international destinations and Bengaluru & Mumbai topping domestic travel. Air India Express...
Jul 22, 2024 22:17
CTTC to Set Up...
CTTC to Set Up Mini Tool Rooms in Odisha
Central Tool Room & Training Centre (CTTC) will set up mini tool rooms in Odisha to train youth in advanced manufacturing and precision engineering.
Jul 22, 2024 21:57
Suzlon Group Q1...
Suzlon Group Q1 Profit Soars 300%, Revenue Rises
Suzlon Group's Q1 PAT nearly tripled to Rs 302 crore on strong revenue growth. The company also boasts a record order book of 3.8 GW. Read more.
Jul 22, 2024 21:36

More News »

Top News

India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36
Mahindra...
Mahindra Logistics Profit Drops 55% in Q1 FY25
Mahindra Logistics Ltd (MLL) reported a 55% decline in standalone profit to Rs 10.15 crore in the April-June quarter due to higher startup costs and expenses.
Jul 22, 2024 22:30
India Rejects 'One-Size-Fits-All' Climate Approach: Chief Economic Advisor
India's Chief Economic Advisor criticizes the West's 'one-size-fits-all' approach to climate change, arguing developing nations need their own solutions. Read why.
Jul 22, 2024 22:28
Mangaluru Airport...
Mangaluru Airport Passenger Traffic Rises 21% | Adani Airports
Mangaluru International Airport sees a 21% surge in passenger traffic in Q1 FY24-25, with Dubai leading international destinations and Bengaluru & Mumbai topping domestic travel. Air India Express...
Jul 22, 2024 22:17
CTTC to Set Up...
CTTC to Set Up Mini Tool Rooms in Odisha
Central Tool Room & Training Centre (CTTC) will set up mini tool rooms in Odisha to train youth in advanced manufacturing and precision engineering.
Jul 22, 2024 21:57

More Top News »

Report Card

PE Ratios
29.50
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 4 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 5 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,568.45
  • Compare
  • Divi's Laboratories Ltd.
  • 4,520.10
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,144.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,639.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,948.50
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,385.00
  • Compare
  • Max Healthcare Institute Ltd.
  • 920.05
  • Compare
  • Alkem Laboratories Ltd.
  • 5,138.15
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Can you please advise SIP in mutual fund. i can take...

Hello sir I am 36 year old I am dependent only my...

Ill be 26yrs old in October. My monthly salary is...

Hello Sir I am an NRI and I still have an old SB...

Hi, I am 38 YO, My Salary is 99K net, I want to earn...

i am a retired PSU employee and in FY 2324, have...

More REDIFFGURUS

RediffGurus

Money question

I have 20 lakhs of funds in my bank account....I am...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close